A new USC Schaeffer Center study published in Health Affairs and led by John Romley and colleagues finds that almost 20% of counties in the nation have high levels of both hesitancy and social vulnerability, and continue to be most at risk of failing to achieve high COVID-19 vaccination coverage.
A team from the USC Schaeffer Center undertook a full assessment of the first year of the pandemic’s mortality burden by measuring years of life lost and accounting for quality-of-life differences, factoring in age, sex, race/ethnicity and comorbidities.
Meet second-year PharmD student Nathalie Iribe, vice president of admission and recruitment for the Associated Students of the School of Pharmacy. Iribe shares her experience growing up in a community where many did not have health insurance and how she became inspired to pursue a career in pharmacy to advocate for accessible healthcare.
Yong (Tiger) Zhang, PhD, assistant professor of pharmacology and pharmaceutical sciences, was awarded a five-year, $2.1 million National Institutes of Health (NIH) grant to reprogram exosomes for biomedical applications.
The numbers tell the story: Since Pfizer received emergency approval for its COVID-19 vaccine in mid-December, quick efforts by USC have contributed to more than 800,000 people in Los Angeles getting inoculated.